Jardiance (empagliflozin)
pCPA File Number:
22059
Negotiation Status:
Active Negotiation
Indication(s):
Adjunct to standard of care therapy for the treatment of chronic heart failure in adults
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CDA-AMC Project Number:
SR0726-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable